相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Febrile neutropenia in EDs: the role of an electronic clinical practice guideline
Charles Lim et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2012)
Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer
Robert S. Phillips et al.
BMC MEDICINE (2012)
Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia
Lillian Sung et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study
Eva Brack et al.
PEDIATRIC BLOOD & CANCER (2012)
Management of febrile neutropenia in an acute oncology service
S. J. Sammut et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2012)
Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients
O. Teuffel et al.
SUPPORTIVE CARE IN CANCER (2012)
Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children-a systematic review of prospective trials
A. Manji et al.
SUPPORTIVE CARE IN CANCER (2012)
Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis
O. Teuffel et al.
ANNALS OF ONCOLOGY (2011)
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Katy L. Cooper et al.
BMC CANCER (2011)
Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients
O. Teuffel et al.
BRITISH JOURNAL OF CANCER (2011)
Prognostic evaluation of febrile neutropaenia in apparently stable adult cancer patients
A. Carmona-Bayonas et al.
BRITISH JOURNAL OF CANCER (2011)
Predicting Individual Risk of Neutropenic Complications in Patients Receiving Cancer Chemotherapy
Gary H. Lyman et al.
CANCER (2011)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients
Matti Vanska et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Use of empiric antimicrobial therapy in neutropenic fever
C. S. Tam et al.
INTERNAL MEDICINE JOURNAL (2011)
Costs of Home Versus Inpatient Treatment for Fever and Neutropenia: Analysis of a Multicenter Randomized Trial
Ann M. Hendricks et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Safety of Early Discharge for Low-Risk Patients With Febrile Neutropenia: A Multicenter Randomized Controlled Trial
James A. Talcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Parental Perspectives on Inpatient Versus Outpatient Management of Pediatric Febrile Neutropenia
Caroline Diorio et al.
JOURNAL OF PEDIATRIC ONCOLOGY NURSING (2011)
Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy
Young Eun Ha et al.
SUPPORTIVE CARE IN CANCER (2011)
Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
Marianne Paesmans et al.
SUPPORTIVE CARE IN CANCER (2011)
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia
Shin Ahn et al.
SUPPORTIVE CARE IN CANCER (2011)
Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network
Edwin Pun Hui et al.
SUPPORTIVE CARE IN CANCER (2011)
The Usefulness of Procalcitonin and C-Reactive Protein as Early Diagnostic Markers of Bacteremia in Cancer Patients with Febrile Neutropenia
Dae Yong Kim et al.
CANCER RESEARCH AND TREATMENT (2011)
Incidence and Impact of Baseline Electrolyte Abnormalities in Patients Admitted with Chemotherapy Induced Febrile Neutropenia
Asim Jamal Shaikh et al.
JOURNAL OF CANCER (2011)
Management of febrile neutropenia: ESMO Clinical Practice Guidelines
J. de Naurois et al.
ANNALS OF ONCOLOGY (2010)
Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours
Anthony R. Mato et al.
CANCER BIOLOGY & THERAPY (2010)
Antibiotic Management of Febrile Neutropenia: Current Developments and Future Directions
J. Mebis et al.
JOURNAL OF CHEMOTHERAPY (2010)
Multiplex Blood PCR in Combination with Blood Cultures for Improvement of Microbiological Documentation of Infection in Febrile Neutropenia
F. Lamoth et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease
Yong Park et al.
LEUKEMIA RESEARCH (2010)
Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients
Kenneth V. I. Rolston et al.
SUPPORTIVE CARE IN CANCER (2010)
Febrile neutropenia in French emergency departments: results of a prospective multicentre survey
Stephanie Andre et al.
CRITICAL CARE (2010)
A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies
M. Moreau et al.
ANNALS OF ONCOLOGY (2009)
Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
Jean Klastersky et al.
CURRENT OPINION IN ONCOLOGY (2009)
Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy
Yasunori Nakagawa et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2009)
Advances in the treatment of neutropenia
David C Dale
Current Opinion in Supportive and Palliative Care (2009)
Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients
Nirmala Devi Baskaran et al.
ANNALS OF HEMATOLOGY (2008)
Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
Linda S. Elting et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge
Catherine Sebban et al.
SUPPORTIVE CARE IN CANCER (2008)
Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice
Helen Innes et al.
SUPPORTIVE CARE IN CANCER (2008)
Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes
J. Zuckermann et al.
ANNALS OF HEMATOLOGY (2008)
Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA
Alison Freifeld et al.
SUPPORTIVE CARE IN CANCER (2008)
Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients
Luciano de Souza Viana et al.
SUPPORTIVE CARE IN CANCER (2008)
Predictive factors of septic shock and mortality in neutropenic patients
Jeddi Ramz et al.
HEMATOLOGY (2007)
Prediction of outcome in cancer patients with febrile neutropenia:: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10
A. Uys et al.
EUROPEAN JOURNAL OF CANCER CARE (2007)
Bacteraernia in febrile neutropenic cancer patients
J. Klastersky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
M. S. Aapro et al.
EUROPEAN JOURNAL OF CANCER (2006)
Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications
Jean Klastersky et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis
Y Lalami et al.
ANNALS OF ONCOLOGY (2006)
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide
P Papaldo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High and low-risk febrile neutropenic patients
F Blot et al.
PRESSE MEDICALE (2004)
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study
HE Innes et al.
BRITISH JOURNAL OF CANCER (2003)
Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis
P Furno et al.
LANCET INFECTIOUS DISEASES (2002)
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
WT Hughes et al.
CLINICAL INFECTIOUS DISEASES (2002)
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
E Rivers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
J Klastersky et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
